Literature DB >> 15749238

Molecular markers in Helicobacter pylori-associated gastric carcinogenesis.

Adrian Gologan1, David Y Graham, Antonia R Sepulveda.   

Abstract

Helicobacter pylori infection is a known risk factor of gastric carcino-genesis. This article presents early molecular alterations associated with H. pylori chronic gastritis and advances in the molecular characterization of preneoplastic intestinal metaplasia (IM) and premalignant gastric mucosal lesions. H. pylori infection induces changes in gene expression, genomic instability and accumulation of gene mutations in the stomach epithelium. Mutations, including LOH and microsatellite instability, and gene hypermethylation are seen not only in gastric cancer, but are already detectable in IM and gastric dysplasia/adenoma. Recent reports using microarray expression analysis identified several gastric epithelial genes that are regulated by H. pylori. Among the many genes showing altered epithelial expression in response to H. pylori, some might be useful as markers to assess gastric cancer risk. Profiles of mutagenesis and gene expression in IM and dysplasia/adenoma have been characterized and represent potential markers of preneoplastic and premalignant lesions during gastric carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15749238     DOI: 10.1016/j.cll.2004.12.002

Source DB:  PubMed          Journal:  Clin Lab Med        ISSN: 0272-2712            Impact factor:   1.935


  17 in total

1.  Evidence-based common sense?

Authors:  Mark Sherman
Journal:  Can Fam Physician       Date:  2008-02       Impact factor: 3.275

2.  Helicobacter pylori infection introduces DNA double-strand breaks in host cells.

Authors:  Katsuhiro Hanada; Tomohisa Uchida; Yoshiyuki Tsukamoto; Masahide Watada; Nahomi Yamaguchi; Kaoru Yamamoto; Seiji Shiota; Masatsugu Moriyama; David Y Graham; Yoshio Yamaoka
Journal:  Infect Immun       Date:  2014-07-28       Impact factor: 3.441

3.  Premalignant lesions in gastric cancer.

Authors:  Kazuo Yashima; Shuji Sasaki; Masaharu Koda; Koichiro Kawaguchi; Kenichi Harada; Yoshikazu Murawaki
Journal:  Clin J Gastroenterol       Date:  2009-12-16

Review 4.  Epigenetic regulation of DNA repair machinery in Helicobacter pylori-induced gastric carcinogenesis.

Authors:  Juliana Carvalho Santos; Marcelo Lima Ribeiro
Journal:  World J Gastroenterol       Date:  2015-08-14       Impact factor: 5.742

Review 5.  Helicobacter pylori and microRNAs: Relation with innate immunity and progression of preneoplastic conditions.

Authors:  Diogo Libânio; Mário Dinis-Ribeiro; Pedro Pimentel-Nunes
Journal:  World J Clin Oncol       Date:  2015-10-10

6.  MGMT and MLH1 methylation in Helicobacter pylori-infected children and adults.

Authors:  Marisa C Alvarez; Juliana C Santos; Nathália Maniezzo; Marcelo S Ladeira; Artur L C da Silva; Isabel C A Scaletsky; José Pedrazzoli; Marcelo L Ribeiro
Journal:  World J Gastroenterol       Date:  2013-05-28       Impact factor: 5.742

7.  Helicobacter, Inflammation, and Gastric Cancer.

Authors:  Antonia R Sepulveda
Journal:  Curr Pathobiol Rep       Date:  2013-03

8.  High-definition CpG methylation of novel genes in gastric carcinogenesis identified by next-generation sequencing.

Authors:  Jorge L Sepulveda; Jorge L Gutierrez-Pajares; Aesis Luna; Yuan Yao; John W Tobias; Steven Thomas; Yanghee Woo; Federico Giorgi; Elena V Komissarova; Andrea Califano; Timothy C Wang; Antonia R Sepulveda
Journal:  Mod Pathol       Date:  2016-01-15       Impact factor: 7.842

9.  H. pylori infection is associated with DNA damage of Lgr5-positive epithelial stem cells in the stomach of patients with gastric cancer.

Authors:  Takeshi Uehara; Deqin Ma; Yuan Yao; John P Lynch; Knashawn Morales; Amy Ziober; Michael Feldman; Hiroyoshi Ota; Antonia R Sepulveda
Journal:  Dig Dis Sci       Date:  2012-09-04       Impact factor: 3.199

10.  Role of DNA-dependent protein kinase catalytic subunit in cancer development and treatment.

Authors:  Feng-Ming Hsu; Shichuan Zhang; Benjamin P C Chen
Journal:  Transl Cancer Res       Date:  2012-05-22       Impact factor: 1.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.